Cell line-specific control of recombinant monoclonal antibody production by CHO cells

Authors

  • Peter M. O'Callaghan,

    1. Department of Chemical and Process Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, UK; telephone: +44-114-222-7505; fax: +44-114-222-7501
    Search for more papers by this author
  • Jane McLeod,

    1. Department of Chemical and Process Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, UK; telephone: +44-114-222-7505; fax: +44-114-222-7501
    Search for more papers by this author
  • Leon P. Pybus,

    1. Department of Chemical and Process Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, UK; telephone: +44-114-222-7505; fax: +44-114-222-7501
    Search for more papers by this author
  • Clare S. Lovelady,

    1. Department of Chemical and Process Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, UK; telephone: +44-114-222-7505; fax: +44-114-222-7501
    Search for more papers by this author
  • Stephen J. Wilkinson,

    1. Department of Chemical and Process Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, UK; telephone: +44-114-222-7505; fax: +44-114-222-7501
    Search for more papers by this author
  • Andrew J. Racher,

    1. Lonza Biologics, 228 Bath Road, Slough SL1 4DX, UK
    Search for more papers by this author
  • Alison Porter,

    1. Lonza Biologics, 228 Bath Road, Slough SL1 4DX, UK
    Search for more papers by this author
  • David C. James

    Corresponding author
    1. Department of Chemical and Process Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, UK; telephone: +44-114-222-7505; fax: +44-114-222-7501
    • Department of Chemical and Process Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, UK; telephone: +44-114-222-7505; fax: +44-114-222-7501.
    Search for more papers by this author

  • Peter M. O'Callaghan, Jane McLeod, and Leon P. Pybus contributed equally to this work.

Abstract

In this study we compare the cellular control of recombinant human IgG4 monoclonal antibody (Mab) synthesis in different CHO cell lines. Based on comprehensive empirical analyses of mRNA and polypeptide synthetic intermediates we constructed cell line-specific mathematical models of recombinant Mab manufacture in seven GS-CHO cell lines varying in specific production rate (qMab) over 350-fold. This comparative analysis revealed that control of qMab involved both genetic construct and cell line-specific factors. With respect to the former, all cell lines exhibited excess production of light chain (LC) mRNA and polypeptide relative to heavy chain (HC) mediated by more rapid LC transcription and enhanced LC mRNA stability. Downstream of this, cell lines differed markedly in their relative rates of recombinant mRNA translation, Mab assembly and secretion although HC mRNA abundance and the rate of HC translation generally exerted most control over qMab—the latter being directly proportional to qMab. This study shows that (i) cell lines capable of high qMab exceed a threshold functional competency in all synthetic processes, (ii) the majority of cells in parental and transfected cell populations are functionally limited and (iii) cell engineering strategies to increase Mab production should be cell line specific. Biotechnol. Bioeng. 2010;106: 938–951. © 2010 Wiley Periodicals, Inc.

Ancillary